Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

Cook IVC Filter Study
Cook IVC Filter Study
Status: Enrolling
Updated:  12/31/1969
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Cook IVC Filter Study
Cook IVC Filter Study
Status: Enrolling
Updated: 12/31/1969
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Cook IVC Filter Study
Cook IVC Filter Study
Status: Enrolling
Updated:  12/31/1969
University of Florida Health - Shands
mi
from
Gainesville, FL
Cook IVC Filter Study
Cook IVC Filter Study
Status: Enrolling
Updated: 12/31/1969
University of Florida Health - Shands
mi
from
Gainesville, FL
Click here to add this to my saved trials
Cook IVC Filter Study
Cook IVC Filter Study
Status: Enrolling
Updated:  12/31/1969
Mount Sinai Medical Center
mi
from
Miami Beach, FL
Cook IVC Filter Study
Cook IVC Filter Study
Status: Enrolling
Updated: 12/31/1969
Mount Sinai Medical Center
mi
from
Miami Beach, FL
Click here to add this to my saved trials
Cook IVC Filter Study
Cook IVC Filter Study
Status: Enrolling
Updated:  12/31/1969
Miami Cardiac and Vascular Institute
mi
from
Miami, FL
Cook IVC Filter Study
Cook IVC Filter Study
Status: Enrolling
Updated: 12/31/1969
Miami Cardiac and Vascular Institute
mi
from
Miami, FL
Click here to add this to my saved trials
Cook IVC Filter Study
Cook IVC Filter Study
Status: Enrolling
Updated:  12/31/1969
University of Chicago
mi
from
Chicago, IL
Cook IVC Filter Study
Cook IVC Filter Study
Status: Enrolling
Updated: 12/31/1969
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Cook IVC Filter Study
Cook IVC Filter Study
Status: Enrolling
Updated:  12/31/1969
OSF St. Francis/Peoria Radiology Research and Education Foundation
mi
from
Peoria, IL
Cook IVC Filter Study
Cook IVC Filter Study
Status: Enrolling
Updated: 12/31/1969
OSF St. Francis/Peoria Radiology Research and Education Foundation
mi
from
Peoria, IL
Click here to add this to my saved trials
Cook IVC Filter Study
Cook IVC Filter Study
Status: Enrolling
Updated:  12/31/1969
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Cook IVC Filter Study
Cook IVC Filter Study
Status: Enrolling
Updated: 12/31/1969
Dartmouth Hitchcock Medical Center
mi
from
Lebanon, NH
Click here to add this to my saved trials
Cook IVC Filter Study
Cook IVC Filter Study
Status: Enrolling
Updated:  12/31/1969
Stony Brook Medicine
mi
from
Stony Brook, NY
Cook IVC Filter Study
Cook IVC Filter Study
Status: Enrolling
Updated: 12/31/1969
Stony Brook Medicine
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Cook IVC Filter Study
Cook IVC Filter Study
Status: Enrolling
Updated:  12/31/1969
North Carolina Memorial Hospital
mi
from
Chapel Hill, NC
Cook IVC Filter Study
Cook IVC Filter Study
Status: Enrolling
Updated: 12/31/1969
North Carolina Memorial Hospital
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Cook IVC Filter Study
Cook IVC Filter Study
Status: Enrolling
Updated:  12/31/1969
Carolinas Medical Center
mi
from
Charlotte, NC
Cook IVC Filter Study
Cook IVC Filter Study
Status: Enrolling
Updated: 12/31/1969
Carolinas Medical Center
mi
from
Charlotte, NC
Click here to add this to my saved trials
Cook IVC Filter Study
Cook IVC Filter Study
Status: Enrolling
Updated:  12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
Cook IVC Filter Study
Cook IVC Filter Study
Status: Enrolling
Updated: 12/31/1969
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Cook IVC Filter Study
Cook IVC Filter Study
Status: Enrolling
Updated:  12/31/1969
Penn State Hershey Medical Center
mi
from
Hershey, PA
Cook IVC Filter Study
Cook IVC Filter Study
Status: Enrolling
Updated: 12/31/1969
Penn State Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
Cook IVC Filter Study
Cook IVC Filter Study
Status: Enrolling
Updated:  12/31/1969
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Cook IVC Filter Study
Cook IVC Filter Study
Status: Enrolling
Updated: 12/31/1969
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Cook IVC Filter Study
Cook IVC Filter Study
Status: Enrolling
Updated:  12/31/1969
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Cook IVC Filter Study
Cook IVC Filter Study
Status: Enrolling
Updated: 12/31/1969
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Cook IVC Filter Study
Cook IVC Filter Study
Status: Enrolling
Updated:  12/31/1969
Rhode Island Hospital
mi
from
Providence, RI
Cook IVC Filter Study
Cook IVC Filter Study
Status: Enrolling
Updated: 12/31/1969
Rhode Island Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Cook IVC Filter Study
Cook IVC Filter Study
Status: Enrolling
Updated:  12/31/1969
The Methodist Hospital - Smith Tower
mi
from
Houston, TX
Cook IVC Filter Study
Cook IVC Filter Study
Status: Enrolling
Updated: 12/31/1969
The Methodist Hospital - Smith Tower
mi
from
Houston, TX
Click here to add this to my saved trials
Cook IVC Filter Study
Cook IVC Filter Study
Status: Enrolling
Updated:  12/31/1969
University of Virginia Medical Center
mi
from
Charlottesville, VA
Cook IVC Filter Study
Cook IVC Filter Study
Status: Enrolling
Updated: 12/31/1969
University of Virginia Medical Center
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Cook IVC Filter Study
Cook IVC Filter Study
Status: Enrolling
Updated:  12/31/1969
MedStar Union Memorial Hospital
mi
from
Baltimore, MD
Cook IVC Filter Study
Cook IVC Filter Study
Status: Enrolling
Updated: 12/31/1969
MedStar Union Memorial Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Cook IVC Filter Study
Cook IVC Filter Study
Status: Enrolling
Updated:  12/31/1969
Abrazo Arrowhead Campus
mi
from
Phoenix, AZ
Cook IVC Filter Study
Cook IVC Filter Study
Status: Enrolling
Updated: 12/31/1969
Abrazo Arrowhead Campus
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Cook IVC Filter Study
Cook IVC Filter Study
Status: Enrolling
Updated:  12/31/1969
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Cook IVC Filter Study
Cook IVC Filter Study
Status: Enrolling
Updated: 12/31/1969
University of Texas Health Science Center at San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
Cook IVC Filter Study
Cook IVC Filter Study
Status: Enrolling
Updated:  12/31/1969
Coastal Vascular & Interventional, PLLC.
mi
from
Pensacola, FL
Cook IVC Filter Study
Cook IVC Filter Study
Status: Enrolling
Updated: 12/31/1969
Coastal Vascular & Interventional, PLLC.
mi
from
Pensacola, FL
Click here to add this to my saved trials
Cook IVC Filter Study
Cook IVC Filter Study
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins University
mi
from
Baltimore, MD
Cook IVC Filter Study
Cook IVC Filter Study
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Cook IVC Filter Study
Cook IVC Filter Study
Status: Enrolling
Updated:  12/31/1969
Alfred Hospital
mi
from
Melbourne,
Cook IVC Filter Study
Cook IVC Filter Study
Status: Enrolling
Updated: 12/31/1969
Alfred Hospital
mi
from
Melbourne,
Click here to add this to my saved trials
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
ARCA Clinical Research Site #157
mi
from
Anchorage, AK
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
ARCA Clinical Research Site #157
mi
from
Anchorage, AK
Click here to add this to my saved trials
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
ARCA Clinical Research Site #383
mi
from
Phoenix, AZ
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
ARCA Clinical Research Site #383
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
ARCA Clinical Research Site #383
mi
from
Phoenix, AZ
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
ARCA Clinical Research Site #383
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
ARCA Clinical Research Site #381
mi
from
East Palo Alto, CA
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
ARCA Clinical Research Site #381
mi
from
East Palo Alto, CA
Click here to add this to my saved trials
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
ARCA Clinical Research Site #186
mi
from
Loma Linda, CA
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
ARCA Clinical Research Site #186
mi
from
Loma Linda, CA
Click here to add this to my saved trials
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
ARCA Clinical Research Site #320
mi
from
Pasadena, CA
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
ARCA Clinical Research Site #320
mi
from
Pasadena, CA
Click here to add this to my saved trials
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
ARCA Clinical Research Site #153
mi
from
Aurora, CO
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
ARCA Clinical Research Site #153
mi
from
Aurora, CO
Click here to add this to my saved trials
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
ARCA Clinical Research Site #380
mi
from
Denver, CO
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
ARCA Clinical Research Site #380
mi
from
Denver, CO
Click here to add this to my saved trials
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
ARCA Clinical Research Site #195
mi
from
Miami, FL
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
ARCA Clinical Research Site #195
mi
from
Miami, FL
Click here to add this to my saved trials
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
ARCA Clinical Research Site #184
mi
from
Tampa, FL
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
ARCA Clinical Research Site #184
mi
from
Tampa, FL
Click here to add this to my saved trials
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
ARCA Clinical Research Site #351
mi
from
Athens, GA
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
ARCA Clinical Research Site #351
mi
from
Athens, GA
Click here to add this to my saved trials
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
ARCA Clinical Research Site #342
mi
from
Oakbrook Terrace, IL
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
ARCA Clinical Research Site #342
mi
from
Oakbrook Terrace, IL
Click here to add this to my saved trials
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
ARCA Clinical Research Site #303
mi
from
Hammond, IN
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
ARCA Clinical Research Site #303
mi
from
Hammond, IN
Click here to add this to my saved trials
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
ARCA Clinical Research Site #388
mi
from
Iowa City, IA
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
ARCA Clinical Research Site #388
mi
from
Iowa City, IA
Click here to add this to my saved trials
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
ARCA Clinical Research Site #127
mi
from
Ypsilanti, MI
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
ARCA Clinical Research Site #127
mi
from
Ypsilanti, MI
Click here to add this to my saved trials
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
ARCA Clinical Research Site #156
mi
from
Minneapolis, MN
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
ARCA Clinical Research Site #156
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
ARCA Clinical Research Site #152
mi
from
Lincoln, NE
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
ARCA Clinical Research Site #152
mi
from
Lincoln, NE
Click here to add this to my saved trials
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
ARCA Clinical Research Site #161
mi
from
Elmer, NJ
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
ARCA Clinical Research Site #161
mi
from
Elmer, NJ
Click here to add this to my saved trials
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
ARCA Clinical Research Site # 179
mi
from
Albany, NY
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
ARCA Clinical Research Site # 179
mi
from
Albany, NY
Click here to add this to my saved trials
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
ARCA Clinical Research Site #181
mi
from
Durham, NC
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
ARCA Clinical Research Site #181
mi
from
Durham, NC
Click here to add this to my saved trials
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
ARCA Clinical Research Site #349
mi
from
Greensboro, NC
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
ARCA Clinical Research Site #349
mi
from
Greensboro, NC
Click here to add this to my saved trials
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
ARCA Clinical Research Site #173
mi
from
Akron, OH
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
ARCA Clinical Research Site #173
mi
from
Akron, OH
Click here to add this to my saved trials
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
ARCA Clinical Research Site #322
mi
from
Cleveland, OH
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
ARCA Clinical Research Site #322
mi
from
Cleveland, OH
Click here to add this to my saved trials
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
ARCA Clinical Research Site #151
mi
from
Columbus, OH
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
ARCA Clinical Research Site #151
mi
from
Columbus, OH
Click here to add this to my saved trials
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
ARCA Clinical Research Site #115
mi
from
Portland, OR
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
ARCA Clinical Research Site #115
mi
from
Portland, OR
Click here to add this to my saved trials
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
ARCA Clinical Research Site # 189
mi
from
Hershey, PA
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
ARCA Clinical Research Site # 189
mi
from
Hershey, PA
Click here to add this to my saved trials
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated:  12/31/1969
ARCA Clinical Research Site #109
mi
from
Lancaster, PA
Genetically Targeted Therapy for the Prevention of Symptomatic Atrial Fibrillation in Patients With Heart Failure
GENETIC-AF - A Genotype-Directed Comparative Effectiveness Trial of Bucindolol and Toprol-XL for Prevention of Symptomatic Atrial Fibrillation/Atrial Flutter in Patients With Heart Failure
Status: Enrolling
Updated: 12/31/1969
ARCA Clinical Research Site #109
mi
from
Lancaster, PA
Click here to add this to my saved trials